SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-013643
Filing Date
2018-12-06
Accepted
2018-12-06 14:40:36
Documents
3
Period of Report
2018-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mdit8k.htm 8-K 25753
2 FORM OF THIRD AMENDMENT TO FORBEARANCE AGREEMENT ex10-1.htm EX-10.1 11315
3 RESIGNATION LETTER OF STEPHEN VON RUMP ex99-1.htm EX-99.1 4689
  Complete submission text file 0001654954-18-013643.txt   43373
Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610
Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290
Medite Cancer Diagnostics, Inc. (Filer) CIK: 0000075439 (see all company filings)

IRS No.: 364296006 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-00935 | Film No.: 181220309
SIC: 3841 Surgical & Medical Instruments & Apparatus